U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Search results

Items: 1 to 100 of 39995

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr1:19018263
GRCh38:
Chr1:18691769
PAX7E199G, E201GHereditary breast ovarian cancer syndromeUncertain significance
(Aug 1, 2020)
criteria provided, single submitter
2.
GRCh37:
Chr1:21771581
GRCh38:
Chr1:21445088
NBPF3M1THereditary breast ovarian cancer syndromeUncertain significance
(Aug 1, 2020)
criteria provided, single submitter
3.
GRCh37:
Chr1:23885773
GRCh38:
Chr1:23559282
ID3S49THereditary breast ovarian cancer syndromeUncertain significance
(Aug 1, 2020)
criteria provided, single submitter
4.
GRCh37:
Chr1:31532185
GRCh38:
Chr1:31059338
PUM1D77HHereditary breast ovarian cancer syndromeUncertain significance
(Aug 1, 2020)
criteria provided, single submitter
5.
GRCh37:
Chr1:45797182
GRCh38:
Chr1:45331510
MUTYHS269fs, S292fs, S384fs, S385fs, S395fs, S399fs, S409fs, S412fsHereditary breast ovarian cancer syndromeLikely pathogenic
(Aug 1, 2020)
criteria provided, single submitter
6.
GRCh37:
Chr1:45798458
GRCh38:
Chr1:45332786
MUTYHR185W, R65W, R158W, R168W, R172W, R157W, R182W, R42WHereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2, not provided
Conflicting interpretations of pathogenicity
(Sep 1, 2022)
criteria provided, conflicting interpretations
7.
GRCh37:
Chr1:45799143
GRCh38:
Chr1:45333471
MUTYHR97Q, R84Q, R70Q, R69Q, R94Q, R80Qnot specified, Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2,
Familial cancer of breast, not provided
Conflicting interpretations of pathogenicity
(Mar 8, 2023)
criteria provided, conflicting interpretations
8.
GRCh37:
Chr1:46521611
GRCh38:
Chr1:46055939
P3R3URF-PIK3R3, PIK3R3R266H, R312H, R283H, R110H, R222H, R185HFamilial cancer of breastUncertain significance
(Feb 1, 2014)
no assertion criteria provided
9.
GRCh37:
Chr1:46714242
GRCh38:
Chr1:46248570
RAD54LD21GInborn genetic diseases, Hereditary breast ovarian cancer syndromeBenign
(Apr 19, 2022)
criteria provided, multiple submitters, no conflicts
10.
GRCh37:
Chr1:46715676
GRCh38:
Chr1:46250004
RAD54LP32RInborn genetic diseases, Hereditary breast ovarian cancer syndromeConflicting interpretations of pathogenicity
(Oct 15, 2022)
criteria provided, conflicting interpretations
11.
GRCh37:
Chr1:46715725
GRCh38:
Chr1:46250053
RAD54LInborn genetic diseases, Hereditary breast ovarian cancer syndromeLikely benign
(Apr 19, 2022)
criteria provided, multiple submitters, no conflicts
12.
GRCh37:
Chr1:46724361
GRCh38:
Chr1:46258689
RAD54LA72PFamilial cancer of breastUncertain significance
(Oct 3, 2022)
criteria provided, single submitter
13.
GRCh37:
Chr1:46725615
GRCh38:
Chr1:46259943
RAD54LHereditary breast ovarian cancer syndromeLikely benign
(Apr 19, 2022)
criteria provided, single submitter
14.
GRCh37:
Chr1:46725716
GRCh38:
Chr1:46260044
RAD54LInborn genetic diseases, Hereditary breast ovarian cancer syndromeLikely benign
(May 3, 2022)
criteria provided, multiple submitters, no conflicts
15.
GRCh37:
Chr1:46725730
GRCh38:
Chr1:46260058
RAD54LInborn genetic diseases, Hereditary breast ovarian cancer syndromeLikely benign
(Apr 19, 2022)
criteria provided, multiple submitters, no conflicts
16.
GRCh37:
Chr1:46726266
GRCh38:
Chr1:46260594
RAD54LR154WHereditary breast ovarian cancer syndromeUncertain significance
(Apr 19, 2022)
criteria provided, single submitter
17.
GRCh37:
Chr1:46726320
GRCh38:
Chr1:46260648
RAD54LHereditary breast ovarian cancer syndromeLikely benign
(Apr 19, 2022)
criteria provided, single submitter
18.
GRCh37:
Chr1:46726525
GRCh38:
Chr1:46260853
RAD54LR202C, R22CHereditary breast ovarian cancer syndromeUncertain significance
(Aug 1, 2020)
criteria provided, single submitter
19.
GRCh37:
Chr1:46726876
GRCh38:
Chr1:46261204
RAD54LHereditary breast ovarian cancer syndromeLikely benign
(Apr 19, 2022)
criteria provided, single submitter
20.
GRCh37:
Chr1:46726933
GRCh38:
Chr1:46261261
RAD54LE256V, E76VInborn genetic diseases, Hereditary breast ovarian cancer syndromeLikely benign
(Sep 4, 2022)
criteria provided, multiple submitters, no conflicts
21.
GRCh37:
Chr1:46727028
GRCh38:
Chr1:46261356
RAD54LG108fs, G288fsFamilial cancer of breastUncertain significance
(Jul 15, 2021)
criteria provided, single submitter
22.
GRCh37:
Chr1:46733105
GRCh38:
Chr1:46267433
RAD54LHereditary breast ovarian cancer syndromeLikely benign
(Apr 19, 2022)
criteria provided, single submitter
23.
GRCh37:
Chr1:46733133
GRCh38:
Chr1:46267461
RAD54LInborn genetic diseases, Hereditary breast ovarian cancer syndromeLikely benign
(Apr 19, 2022)
criteria provided, multiple submitters, no conflicts
24.
GRCh37:
Chr1:46733336
GRCh38:
Chr1:46267664
RAD54LHereditary breast ovarian cancer syndromeBenign
(Apr 19, 2022)
criteria provided, single submitter
25.
GRCh37:
Chr1:46733359
GRCh38:
Chr1:46267687
RAD54LHereditary breast ovarian cancer syndromeBenign
(Apr 19, 2022)
criteria provided, single submitter
26.
GRCh37:
Chr1:46736382
GRCh38:
Chr1:46270710
RAD54LR185Q, R365QHereditary breast ovarian cancer syndromeUncertain significance
(Aug 1, 2020)
criteria provided, single submitter
27.
GRCh37:
Chr1:46736426
GRCh38:
Chr1:46270754
RAD54LR200W, R380WHereditary breast ovarian cancer syndrome, Premature ovarian failureConflicting interpretations of pathogenicity
(Apr 19, 2022)
criteria provided, conflicting interpretations
28.
GRCh37:
Chr1:46738282
GRCh38:
Chr1:46272610
RAD54LHereditary breast ovarian cancer syndromeLikely benign
(Apr 19, 2022)
criteria provided, single submitter
29.
GRCh37:
Chr1:46738306-46738307
GRCh38:
Chr1:46272634-46272635
RAD54LHereditary breast ovarian cancer syndromeLikely benign
(Apr 19, 2022)
criteria provided, single submitter
30.
GRCh37:
Chr1:46738349
GRCh38:
Chr1:46272677
RAD54LT237I, T417IFamilial cancer of breastUncertain significance
(Dec 12, 2022)
criteria provided, single submitter
31.
GRCh37:
Chr1:46738398
GRCh38:
Chr1:46272726
RAD54LInborn genetic diseases, Hereditary breast ovarian cancer syndromeLikely benign
(Apr 19, 2022)
criteria provided, multiple submitters, no conflicts
32.
GRCh37:
Chr1:46738506
GRCh38:
Chr1:46272834
RAD54LHereditary breast ovarian cancer syndromeLikely benign
(Apr 19, 2022)
criteria provided, single submitter
33.
GRCh37:
Chr1:46739042-46739044
GRCh38:
Chr1:46273370-46273372
RAD54LD285del, D465delHereditary breast ovarian cancer syndromeUncertain significance
(Apr 19, 2022)
criteria provided, single submitter
34.
GRCh37:
Chr1:46739221
GRCh38:
Chr1:46273549
RAD54LHereditary breast ovarian cancer syndromeLikely benign
(Apr 19, 2022)
criteria provided, single submitter
35.
GRCh37:
Chr1:46739285
GRCh38:
Chr1:46273613
RAD54LHereditary breast ovarian cancer syndromeLikely benign
(Apr 19, 2022)
criteria provided, single submitter
36.
GRCh37:
Chr1:46739332
GRCh38:
Chr1:46273660
RAD54LT328I, T508IHereditary breast ovarian cancer syndromeUncertain significance
(Apr 19, 2022)
criteria provided, single submitter
37.
GRCh37:
Chr1:46739409
GRCh38:
Chr1:46273737
RAD54LR354C, R534CInborn genetic diseases, Hereditary breast ovarian cancer syndromeBenign/Likely benign
(Oct 10, 2022)
criteria provided, multiple submitters, no conflicts
38.
GRCh37:
Chr1:46739739
GRCh38:
Chr1:46274067
RAD54LHereditary breast ovarian cancer syndromeLikely benign
(Apr 19, 2022)
criteria provided, single submitter
39.
GRCh37:
Chr1:46739752
GRCh38:
Chr1:46274080
RAD54LHereditary breast ovarian cancer syndromeLikely benign
(Apr 19, 2022)
criteria provided, single submitter
40.
GRCh37:
Chr1:46739754
GRCh38:
Chr1:46274082
RAD54LHereditary breast ovarian cancer syndromeLikely benign
(Apr 19, 2022)
criteria provided, single submitter
41.
GRCh37:
Chr1:46739755
GRCh38:
Chr1:46274083
RAD54LHereditary breast ovarian cancer syndromeLikely benign
(Apr 19, 2022)
criteria provided, single submitter
42.
GRCh37:
Chr1:46739814
GRCh38:
Chr1:46274142
RAD54LHereditary breast ovarian cancer syndromeLikely benign
(Apr 19, 2022)
criteria provided, single submitter
43.
GRCh37:
Chr1:46740268
GRCh38:
Chr1:46274596
RAD54LI403T, I583TInborn genetic diseases, Hereditary breast ovarian cancer syndromeLikely benign
(Oct 21, 2022)
criteria provided, multiple submitters, no conflicts
44.
GRCh37:
Chr1:46740289
GRCh38:
Chr1:46274617
RAD54LM410T, M590TInborn genetic diseases, Familial cancer of breastUncertain significance
(Jan 21, 2023)
criteria provided, multiple submitters, no conflicts
45.
GRCh37:
Chr1:46743645
GRCh38:
Chr1:46277973
LRRC41, RAD54LH496Y, H676YInborn genetic diseases, Hereditary breast ovarian cancer syndromeConflicting interpretations of pathogenicity
(Apr 19, 2022)
criteria provided, conflicting interpretations
46.
GRCh37:
Chr1:46743738
GRCh38:
Chr1:46278066
LRRC41, RAD54LHereditary breast ovarian cancer syndromeLikely benign
(Apr 19, 2022)
criteria provided, single submitter
47.
GRCh37:
Chr1:46743773
GRCh38:
Chr1:46278101
LRRC41, RAD54LR508H, R688HHereditary breast ovarian cancer syndromeLikely benign
(Apr 19, 2022)
criteria provided, single submitter
48.
GRCh37:
Chr1:46743900
GRCh38:
Chr1:46278228
LRRC41, RAD54LInborn genetic diseases, Hereditary breast ovarian cancer syndromeBenign
(Apr 19, 2022)
criteria provided, multiple submitters, no conflicts
49.
GRCh37:
Chr1:46743907
GRCh38:
Chr1:46278235
LRRC41, RAD54LF553V, F733VHereditary breast ovarian cancer syndromeUncertain significance
(Apr 19, 2022)
criteria provided, single submitter
50.
GRCh37:
Chr1:120539916
GRCh38:
Chr1:119997293
NOTCH2P152LHereditary breast ovarian cancer syndromeUncertain significance
(Aug 1, 2020)
criteria provided, single submitter
51.
GRCh37:
Chr1:146743928
GRCh38:
Chr1:147272267
CHD1LL138P, L215P, L256P, L267P, L306P, L319P, L347P, L419PHereditary breast ovarian cancer syndromeUncertain significance
(Aug 1, 2020)
criteria provided, single submitter
52.
GRCh37:
Chr1:159032484
GRCh38:
Chr1:159062694
AIM2not provided, Hereditary breast ovarian cancer syndromeConflicting interpretations of pathogenicity
(Aug 1, 2020)
criteria provided, conflicting interpretations
53.
GRCh37:
Chr1:193099337
GRCh38:
Chr1:193130207
CDC73R91*Familial cancer of breast, Hyperparathyroidism 1, Parathyroid carcinoma
Pathogenic
(Oct 18, 2022)
criteria provided, multiple submitters, no conflicts
54.
GRCh37:
Chr1:242023882
GRCh38:
Chr1:241860580
EXO1G274RHereditary breast ovarian cancer syndromeUncertain significance
(Aug 1, 2020)
criteria provided, single submitter
55.
GRCh37:
Chr2:32733184
GRCh38:
Chr2:32508117
BIRC6L3279F, L3280FHereditary breast ovarian cancer syndromeUncertain significance
(Aug 1, 2020)
criteria provided, single submitter
56.
GRCh37:
Chr2:47601012
GRCh38:
Chr2:47373873
EPCAMP84SHereditary breast ovarian cancer syndromeUncertain significance
(May 1, 2019)
criteria provided, single submitter
57.
GRCh37:
Chr2:47601150
GRCh38:
Chr2:47374011
EPCAMD130YHereditary breast ovarian cancer syndromeUncertain significance
(May 1, 2019)
criteria provided, single submitter
58.
GRCh37:
Chr2:47606171
GRCh38:
Chr2:47379032
EPCAMV212GHereditary breast ovarian cancer syndromeUncertain significance
(May 1, 2019)
criteria provided, single submitter
59.
GRCh37:
Chr2:47630344
GRCh38:
Chr2:47403205
MSH2P5Qnot specified, Hereditary breast ovarian cancer syndrome, Ovarian cancer,
not provided, Lynch syndrome 1, Hereditary nonpolyposis colorectal neoplasms,
Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome
Conflicting interpretations of pathogenicity
(Feb 6, 2023)
criteria provided, conflicting interpretations
60.
GRCh37:
Chr2:47630410
GRCh38:
Chr2:47403271
MSH2P27LHereditary nonpolyposis colorectal neoplasms, not provided, Hereditary breast ovarian cancer syndrome,
Lynch syndrome 1, Hereditary cancer-predisposing syndrome, Lynch syndrome
Conflicting interpretations of pathogenicity
(Oct 18, 2022)
criteria provided, conflicting interpretations
61.
GRCh37:
Chr2:47630448
GRCh38:
Chr2:47403309
MSH2G40SHereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, not specified,
Hereditary breast ovarian cancer syndrome, not provided
Conflicting interpretations of pathogenicity
(Oct 17, 2022)
criteria provided, conflicting interpretations
62.
GRCh37:
Chr2:47635594
GRCh38:
Chr2:47408455
MSH2V89A, V23AHereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms, not specified,
Hereditary breast ovarian cancer syndrome
Conflicting interpretations of pathogenicity
(Oct 24, 2022)
criteria provided, conflicting interpretations
63.
GRCh37:
Chr2:47635614
GRCh38:
Chr2:47408475
MSH2R96C, R30CBreast-ovarian cancer, familial, susceptibility to, 1, not specified, Hereditary nonpolyposis colorectal neoplasms,
Hereditary cancer-predisposing syndrome
Conflicting interpretations of pathogenicity
(Aug 22, 2022)
criteria provided, conflicting interpretations
64.
GRCh37:
Chr2:47637314
GRCh38:
Chr2:47410175
MSH2V150F, V84FHereditary cancer-predisposing syndrome, not specified, Hereditary breast ovarian cancer syndrome
Conflicting interpretations of pathogenicity
(Aug 2, 2022)
criteria provided, conflicting interpretations
65.
GRCh37:
Chr2:47637371
GRCh38:
Chr2:47410232
MSH2I169V, I103VLynch syndromeLikely benign
(Sep 5, 2013)
reviewed by expert panel
66.
GRCh37:
Chr2:47655013-47657819
GRCh38:
Chr2:47427874-47430680
MSH2Endometrial carcinoma, Turcot syndrome, Lynch syndrome 5,
Lynch syndrome 1, Familial cancer of breast
Pathogenic
(Aug 11, 2021)
criteria provided, single submitter
67.
GRCh37:
Chr2:47657059
GRCh38:
Chr2:47429920
MSH2Q419K, Q353KLynch syndromeLikely benign
(Sep 5, 2013)
reviewed by expert panel
68.
GRCh37:
Chr2:47672725
GRCh38:
Chr2:47445586
MSH2P439A, P373AHereditary cancer-predisposing syndrome, not provided, Hereditary breast ovarian cancer syndrome,
Hereditary nonpolyposis colorectal neoplasms
Conflicting interpretations of pathogenicity
(Aug 16, 2022)
criteria provided, conflicting interpretations
69.
GRCh37:
Chr2:47690284
GRCh38:
Chr2:47463145
MSH2R435G, R501GHereditary nonpolyposis colorectal neoplasms, Hereditary breast ovarian cancer syndromeUncertain significance
(Aug 30, 2021)
criteria provided, multiple submitters, no conflicts
70.
GRCh37:
Chr2:47693924
GRCh38:
Chr2:47466785
MSH2K546N, K480NHereditary nonpolyposis colorectal neoplasms, Lynch syndrome, Hereditary breast ovarian cancer syndrome
Uncertain significance
(Aug 26, 2021)
criteria provided, multiple submitters, no conflicts
71.
GRCh37:
Chr2:47702250
GRCh38:
Chr2:47475111
MSH2P616S, P550SHereditary nonpolyposis colorectal neoplasms, not provided, Hereditary breast ovarian cancer syndrome,
Hereditary cancer-predisposing syndrome
Conflicting interpretations of pathogenicity
(Sep 8, 2022)
criteria provided, conflicting interpretations
72.
GRCh37:
Chr2:47703564
GRCh38:
Chr2:47476425
MSH2M688I, M622IHereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome, Hereditary nonpolyposis colorectal neoplasms,
not provided, not specified, Lynch syndrome 1
Conflicting interpretations of pathogenicity
(Feb 6, 2023)
criteria provided, conflicting interpretations
73.
GRCh37:
Chr2:47703709
GRCh38:
Chr2:47476570
MSH2R737G, R671GHereditary breast ovarian cancer syndrome, not provided, Hereditary nonpolyposis colorectal neoplasms,
Hereditary cancer-predisposing syndrome
Conflicting interpretations of pathogenicity
(Oct 5, 2022)
criteria provided, conflicting interpretations
74.
GRCh37:
Chr2:47705607
GRCh38:
Chr2:47478468
MSH2T803A, T737Anot specified, Hereditary nonpolyposis colorectal neoplasms, Hereditary breast ovarian cancer syndrome,
Hereditary cancer-predisposing syndrome
Uncertain significance
(Sep 26, 2022)
criteria provided, multiple submitters, no conflicts
75.
GRCh37:
Chr2:47705625
GRCh38:
Chr2:47478486
MSH2E809K, E743KHereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, not specified,
Hereditary breast ovarian cancer syndrome
Conflicting interpretations of pathogenicity
(Nov 4, 2022)
criteria provided, conflicting interpretations
76.
GRCh37:
Chr2:47707909
GRCh38:
Chr2:47480770
MSH2K845E, K779EHereditary cancer-predisposing syndrome, not specified, Hereditary breast ovarian cancer syndrome,
Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome, Lynch syndrome 1
Conflicting interpretations of pathogenicity
(Sep 8, 2022)
criteria provided, conflicting interpretations
77.
GRCh37:
Chr2:48010602
GRCh38:
Chr2:47783463
MSH6R77QHereditary nonpolyposis colorectal neoplasms, Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome
Uncertain significance
(Jan 25, 2022)
criteria provided, multiple submitters, no conflicts
78.
GRCh37:
Chr2:48010605
GRCh38:
Chr2:47783466
MSH6R78KHereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, Lynch syndrome 5,
not specified, Hereditary breast ovarian cancer syndrome
Uncertain significance
(Sep 21, 2022)
criteria provided, multiple submitters, no conflicts
79.
GRCh37:
Chr2:48023107
GRCh38:
Chr2:47795968
MSH6R178CHereditary nonpolyposis colorectal neoplasms, not provided, Hereditary breast ovarian cancer syndrome,
Hereditary cancer-predisposing syndrome, Lynch syndrome 5, not specified
Conflicting interpretations of pathogenicity
(Oct 5, 2022)
criteria provided, conflicting interpretations
80.
GRCh37:
Chr2:48025850
GRCh38:
Chr2:47798711
MSH6R243H, R113HHereditary nonpolyposis colorectal neoplasms, not provided, Hereditary breast ovarian cancer syndrome,
Hereditary cancer-predisposing syndrome, Lynch syndrome
Conflicting interpretations of pathogenicity
(Mar 7, 2023)
criteria provided, conflicting interpretations
81.
GRCh37:
Chr2:48026194
GRCh38:
Chr2:47799055
MSH6D228N, D358N, D56NHereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndromeUncertain significance
(Dec 8, 2020)
criteria provided, multiple submitters, no conflicts
82.
GRCh37:
Chr2:48026260
GRCh38:
Chr2:47799121
MSH6D250N, D380N, D78NHereditary breast ovarian cancer syndrome, Hereditary nonpolyposis colorectal neoplasmsUncertain significance
(Sep 2, 2021)
criteria provided, multiple submitters, no conflicts
83.
GRCh37:
Chr2:48026312
GRCh38:
Chr2:47799173
MSH6Y397C, Y267C, Y95CHereditary nonpolyposis colorectal neoplasms, not provided, Hereditary breast ovarian cancer syndrome,
Lynch syndrome 5, Hereditary cancer-predisposing syndrome, Mismatch repair cancer syndrome 3,
Endometrial carcinoma, Lynch syndrome 5, not specified,
Lynch syndrome
Conflicting interpretations of pathogenicity
(Dec 27, 2022)
criteria provided, conflicting interpretations
84.
GRCh37:
Chr2:48026782
GRCh38:
Chr2:47799643
MSH6R554C, R252C, R424CHereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, not provided,
Hereditary breast ovarian cancer syndrome
Conflicting interpretations of pathogenicity
(Oct 5, 2022)
criteria provided, conflicting interpretations
85.
GRCh37:
Chr2:48027348
GRCh38:
Chr2:47800209
MSH6N742K, N612K, N440KHereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome,
not provided
Uncertain significance
(Oct 21, 2022)
criteria provided, multiple submitters, no conflicts
86.
GRCh37:
Chr2:48027419
GRCh38:
Chr2:47800280
MSH6H464L, H636L, H766LHereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndromeUncertain significance
(May 1, 2019)
criteria provided, multiple submitters, no conflicts
87.
GRCh37:
Chr2:48027671
GRCh38:
Chr2:47800532
MSH6Y850S, Y720S, Y548SHereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndromeUncertain significance
(May 1, 2019)
criteria provided, multiple submitters, no conflicts
88.
GRCh37:
Chr2:48028007
GRCh38:
Chr2:47800868
MSH6I962T, I832T, I660THereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, not provided,
Hereditary breast ovarian cancer syndrome
Uncertain significance
(Nov 17, 2021)
criteria provided, multiple submitters, no conflicts
89.
GRCh37:
Chr2:48028265
GRCh38:
Chr2:47801126
MSH6Q918R, Q1048R, Q746RHereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome, Hereditary nonpolyposis colorectal neoplasms
Uncertain significance
(Aug 24, 2022)
criteria provided, multiple submitters, no conflicts
90.
GRCh37:
Chr2:48028273
GRCh38:
Chr2:47801134
MSH6V1051I, V749I, V921IHereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, not provided,
not specified, Hereditary breast ovarian cancer syndrome, Lynch syndrome 5
Conflicting interpretations of pathogenicity
(Oct 31, 2022)
criteria provided, conflicting interpretations
91.
GRCh37:
Chr2:48032851
GRCh38:
Chr2:47805712
MSH6Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, Familial cancer of breast
Uncertain significance
(May 15, 2022)
criteria provided, multiple submitters, no conflicts
92.
GRCh37:
Chr2:48033385
GRCh38:
Chr2:47806246
MSH6A1230G, A1100G, A928GHereditary nonpolyposis colorectal neoplasms, Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome
Conflicting interpretations of pathogenicity
(Sep 30, 2022)
criteria provided, conflicting interpretations
93.
GRCh37:
Chr2:48033763
GRCh38:
Chr2:47806624
MSH6K1325T, K1195T, K1023TBreast-ovarian cancer, familial, susceptibility to, 1, Hereditary nonpolyposis colorectal neoplasmsUncertain significance
(Sep 19, 2022)
criteria provided, multiple submitters, no conflicts
94.
GRCh37:
Chr2:48033792-48033795
GRCh38:
Chr2:47806653-47806656
MSH6Lynch syndromeLikely benign
(Jun 21, 2019)
reviewed by expert panel
95.
GRCh37:
Chr2:79971512
GRCh38:
Chr2:79744386
CTNNA2Hereditary breast ovarian cancer syndromePathogenic
(Aug 1, 2020)
criteria provided, single submitter
96.
GRCh37:
Chr2:179505328
GRCh38:
Chr2:178640601
TTNE10987*, E11914*, E13555*, E4490*, E4615*, E4682*Familial cancer of breastLikely pathogenic
(Apr 20, 2022)
criteria provided, single submitter
97.
GRCh37:
Chr2:190708712
GRCh38:
Chr2:189843986
PMS1R202K, R141K, R26KHereditary breast ovarian cancer syndromeLikely benign
(May 3, 2020)
criteria provided, single submitter
98.
GRCh37:
Chr2:190719037
GRCh38:
Chr2:189854311
PMS1E171K, E286K, E308K, E347KHereditary breast ovarian cancer syndromeUncertain significance
(Aug 1, 2020)
criteria provided, single submitter
99.
GRCh37:
Chr2:190719607
GRCh38:
Chr2:189854881
PMS1E537K, E361K, E476K, E498Knot specified, Hereditary breast ovarian cancer syndromeLikely benign
(Jul 27, 2021)
criteria provided, multiple submitters, no conflicts
100.
GRCh37:
Chr2:202136272
GRCh38:
Chr2:201271549
CASP8Autoimmune lymphoproliferative syndrome type 2B, Familial cancer of breast, Lung cancer,
Hepatocellular carcinoma, Autoimmune lymphoproliferative syndrome type 2B
Benign/Likely benign
(Oct 22, 2022)
criteria provided, multiple submitters, no conflicts
Format
Items per page
Sort by
Choose Destination